GLOBAL Trademark
Trademark Overview
On Tuesday, June 18, 1996, a trademark application was filed for GLOBAL with the United States Patent and Trademark Office. The USPTO has given the GLOBAL trademark a serial number of 75121001. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, May 23, 2009. This trademark is owned by Global Pharmaceutical Corporation. The GLOBAL trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceuticals, namely, promethazine, for treatment of allergic reactions and for control of nausea and vomiting; chloroquine, for treatment of malaria and extraintestinal amebiasis; prednisolone, for treatment of adrenocortical insufficiency, rheumatic disorders and collagen diseases; tetracycline, for treatment of infections caused by gram-negative microorganisms; methyltestosterone, for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone such as in delayed puberty; meprobamate, for management of anxiety disorders; hydrocortisone, for replacement therapy in adrenocortical therapy and as anti-inflammatory agent in disorders of many organ systems; hyoscyamine, for adjunctive therapy in treatment of peptic ulcer and for control of gastric secretion in spastic colitis; chlordiazepoxide, for relief of anxiety and tension; piperazine, for treatment of roundworms and pinworms; pancrealipase; for treatment of chronic pancreatitis and cystic f...
General Information
| Serial Number | 75121001 |
| Word Mark | GLOBAL |
| Filing Date | Tuesday, June 18, 1996 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Saturday, May 23, 2009 |
| Registration Number | 2198827 |
| Registration Date | Tuesday, October 20, 1998 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 11, 1997 |
Trademark Statements
| Goods and Services | pharmaceuticals, namely, promethazine, for treatment of allergic reactions and for control of nausea and vomiting; chloroquine, for treatment of malaria and extraintestinal amebiasis; prednisolone, for treatment of adrenocortical insufficiency, rheumatic disorders and collagen diseases; tetracycline, for treatment of infections caused by gram-negative microorganisms; methyltestosterone, for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone such as in delayed puberty; meprobamate, for management of anxiety disorders; hydrocortisone, for replacement therapy in adrenocortical therapy and as anti-inflammatory agent in disorders of many organ systems; hyoscyamine, for adjunctive therapy in treatment of peptic ulcer and for control of gastric secretion in spastic colitis; chlordiazepoxide, for relief of anxiety and tension; piperazine, for treatment of roundworms and pinworms; pancrealipase; for treatment of chronic pancreatitis and cystic fibrosis; vitamins and nutritional supplements, namely, calcium gluconate, ferrous gluconate, shark cartilage, melatonin, collagen and fish liver oil |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Saturday, May 23, 2009 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, April 20, 1993 |
| First Use In Commerce Date | Monday, November 28, 1994 |
Trademark Owner History
| Party Name | IMPAX LABORATORIES, INC. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | HAYWARD, CA 94544 |
| Party Name | Global Pharmaceutical Corporation |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 191245694 |
| Party Name | Global Pharmaceutical Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 191245694 |
| Party Name | Global Pharmaceutical Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 191245694 |
Trademark Events
| Event Date | Event Description |
| Saturday, May 23, 2009 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
| Friday, May 9, 2008 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, May 9, 2008 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, August 8, 2007 | CASE FILE IN TICRS |
| Friday, May 27, 2005 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, June 17, 2004 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Thursday, May 6, 2004 | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED |
| Thursday, May 6, 2004 | PAPER RECEIVED |
| Tuesday, October 20, 1998 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, August 27, 1998 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, August 4, 1998 | ASSIGNED TO EXAMINER |
| Monday, July 27, 1998 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, July 10, 1998 | USE AMENDMENT FILED |
| Tuesday, June 9, 1998 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, December 8, 1997 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, November 11, 1997 | PUBLISHED FOR OPPOSITION |
| Friday, October 10, 1997 | NOTICE OF PUBLICATION |
| Thursday, September 11, 1997 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, August 28, 1997 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 6, 1997 | FINAL REFUSAL MAILED |
| Friday, November 22, 1996 | NON-FINAL ACTION MAILED |
| Thursday, November 14, 1996 | ASSIGNED TO EXAMINER |
